Publication | Open Access
Molecular‐based diagnosis of multiple sclerosis and its progressive stage
54
Citations
27
References
2017
Year
CNS biological processes reflected by CSF biomarkers are robust, stable, disease specific, or even disease stage specific. This opens opportunities for broad utilization of CSF biomarkers in drug development and precision medicine for CNS disorders. Ann Neurol 2017;82:795-812.
| Year | Citations | |
|---|---|---|
Page 1
Page 1